We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Vegetable-Rich Diet Slows Development of Arterial Plaques

By Biotechdaily staff writers
Posted on 07 Jul 2006
Researchers working with a mouse model of atherosclerosis have shown that a diet rich in green and yellow vegetables slows the processes leading to the formation of arterial plaques.

Investigators at the Wake Forest University School of Medicine (Winston-Salem, NC, USA) worked with a line of mice that had been genetically engineered to lack the gene for the LDL (low density lipoprotein) receptor. More...


The mice were divided into two groups: 53 animals were fed a vegetable-free control diet, while 54 animals were fed the same diet with 30% of the calories replaced by an equal-parts mixture of freeze-dried peas, green beans, broccoli, corn, and carrots. After 16 weeks, aortic atherosclerosis was estimated by determining cholesteryl ester content. Plasma total cholesterol, VLDL (very low density lipoproteins) plus LDL cholesterol, serum amyloid A, and body weight were determined and compared.

Results published in the June 2006 issue of the Journal of Nutrition revealed that aortic atherosclerosis was reduced 38% in the mice fed the vegetable-rich diet. Plasma total cholesterol (–12%), VLDL + LDL cholesterol (–32%), serum amyloid A (–37%), and body weight (–7%) were also lower in these mice at the end of the treatment period.

"It is well known that atherosclerosis progression is intimately linked with inflammation in the arteries,” explained first author Dr. Michael R. Adams, professor of pathology at the Wake Forest University School of Medicine. "Our results, combined with other studies, support the idea that increased vegetable consumption inhibits atherosclerosis progression through antioxidant and anti-inflammatory pathways. Although the pathways involved remain uncertain, the results indicate that a diet rich in green and yellow vegetables inhibits the development of hardening of the arteries and may reduce the risk of heart disease.”



Related Links:
Wake Forest University School of Medicine

Gold Member
Quantitative POC Immunoassay Analyzer
EASY READER+
New
Gold Member
Aspiration System
VACUSAFE
New
POC Immunoassay Analyzer
Procise DX
New
LAIR2 Antibody Pair Set
LAIR2 Antibody Pair [Biotin]
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image

Urine-Based Multi-Cancer Screening Test Receives FDA Breakthrough Device Designation

Early detection across multiple cancers remains a major unmet need in population screening. Non-invasive approaches that can be delivered at scale may broaden access and shift diagnoses to earlier stages.... Read more

Molecular Diagnostics

view channel
Image: The new approach focuses on CpG DNA methylation, a chemical modification of cytosine and guanine bases, using tumor samples to develop a computational model that distinguishes among 21 cancer types (photo credet: 123RF)

Machine Learning Model Uses DNA Methylation to Predict Tumor Origin in Cancers of Unknown Primary

Cancers of unknown primary (CUP) are metastatic malignancies in which the primary site cannot be identified, complicating treatment selection. Many patients consequently receive broad, nonspecific chemotherapy... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.